Edition:
United States

Insmed Inc (INSM.OQ)

INSM.OQ on NASDAQ Stock Exchange Global Select Market

26.63USD
12:19pm EST
Change (% chg)

$-0.44 (-1.63%)
Prev Close
$27.07
Open
$26.95
Day's High
$27.08
Day's Low
$26.47
Volume
97,627
Avg. Vol
336,103
52-wk High
$31.56
52-wk Low
$11.31

Select another date:

Fri, Sep 28 2018

Insmed's treatment-resistant lung disease drug gets FDA approval

The U.S. Food and Drug Administration on Friday approved Insmed Inc's lead drug to treat a rare, chronic lung disease, making it the first approved treatment in the United States for the condition.

UPDATE 1-Insmed's treatment-resistant lung disease drug gets FDA approval

Sept 28 The U.S. Food and Drug Administration on Friday approved Insmed Inc's lead drug to treat a rare, chronic lung disease, making it the first approved treatment in the United States for the condition.

Insmed's treatment-resistant lung disease drug gets FDA approval

Sept 28 The U.S. Food and Drug Administration on Friday approved Insmed Inc's lead drug to treat a rare, chronic lung disease, making it the first approved treatment in the United States for the condition.

Select another date: